<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>We assessed the relationship of Epstein-Barr virus (EBV) serology to the presence or absence of EBV genome in 39 cases of <z:e sem="disease" ids="C0019829" disease_type="Neoplastic Process" abbrv="hd">Hodgkin's disease</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">HD</z:e>) </plain></SENT>
<SENT sid="1" pm="."><plain>Biopsies from patients included in 2 previous published studies, 1 involving patients from the United States (eastern Massachusetts) and 1 from Denmark, were evaluated for EBV (EBER-1) and latent membrane protein (LMP-1) </plain></SENT>
<SENT sid="2" pm="."><plain>The presence of EBV in Reed-Sternberg cells in the biopsies correlated with the histologic subtype of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">HD</z:e> (mixed cellularity and lymphocyte <z:mpath ids='MPATH_63'>depletion</z:mpath>) but not with IgG antibody titers against the <z:mp ids='MP_0001799'>viral</z:mp> capsid antigen (VCA) </plain></SENT>
<SENT sid="3" pm="."><plain>These data suggest that, unlike Burkitt's <z:hpo ids='HP_0002665'>lymphoma</z:hpo>, the IgG antibody against VCA is not predictive of the presence or absence of EBV in Reed-Sternberg cells in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">HD</z:e> </plain></SENT>
<SENT sid="4" pm="."><plain>The predictive value of other antibodies should be evaluated </plain></SENT>
</text></document>